Development of a Novel Human Single Chain Antibody Against EGFRVIII Antigen by Phage Display Technology
Purpose: EGFRvIII as the most common mutant variant of the epidermal growth factor receptor is resulting from deletion of exons 2-7 in the coding sequence and junction of exons 1 and 8 through a novel glycine residue. EGFRvIII is highly expressed in glioblastoma, carcinoma of the breast, ovary, and...
Saved in:
Main Authors: | Leila Rahbarnia (Author), Safar Farajnia (Author), Hossein Babaei (Author), Jafar Majidi (Author), Bahman Akbari (Author), Shiva Ahdi khosroshahi (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2016-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chaperone-Assisted Soluble Expression of a Humanized Anti-EGFR ScFv Antibody in E. Coli
by: Kamal Veisi, et al.
Published: (2015) -
Evolution of phage display libraries for therapeutic antibody discovery
by: Yang Zhang
Published: (2023) -
Identification of Novel Single Chain Fragment Variable Antibodies Against TNF-α Using Phage Display Technology
by: Ali Akbar Alizadeh, et al.
Published: (2015) -
In Vivo Evaluation of <sup>68</sup>Ga-Labeled NOTA-EGFRvIII Aptamer in EGFRvIII-Positive Glioblastoma Xenografted Model
by: Jun Young Park, et al.
Published: (2024) -
In situ antibody phage display yields optimal inhibitors of integrin α11/β1
by: Eugenio Gallo, et al.
Published: (2020)